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The location of secondary tumours is determined, in part, by
anatomical blood flow and by interactions between tumour cells
and host organs (Nicolson, 1988a). During hematogenous metas-
tasis formation some tumour cells show selective colonization of
various organs. This is the result of a multistep sequential process,
determined by specific properties of the tumour cell as well as the
host organ (Nicolson, 1988a). The adhesion of blood-borne malig-
nant cells to microvascular vessel walls and the migration of the
metastatic cells to the underlying extracellular matrix (ECM) and
eventually into the host organ are very important in this process
(Nicolson, 1989). During the adhesive interactions between
tumour cells and the vascular ECM certain molecules function for
primary ECM contact, adhesion stabilization and cell migration
into the host organ (Doerr et al, 1989; Nicolson, 1989, 1991). In
various organs ECM composition has been found to be different
which could be important in tumour cell–ECM adhesion
(Nicolson, 1995). Additionally, some tumours, such as colon
carcinomas, produce their own ECM components, and these
components can modify peritumoural ECM composition (Burtin et
al, 1983; Grigioni et al, 1986). In some tumour systems the expres-
sion of ECM components by tumour cells, such as the expression
of oncofetal fibronectin (FN) by colorectal carcinomas, correlates
with poor prognosis (Inufusa et al, 1995). Also, various immuno-
histochemical studies have investigated the expression of ECM-
binding integrins in normal colon tissue and in colon carcinomas
of different stages, including their metastases (Lindmark et al,
1993; Takazawa, 1995). Although certain patterns of integrin
expression were found, it was apparent that there is a broad spec-
trum of expression of these molecules (reviewed by Agrez and
Bates, 1994). The reported differences in immunostaining patterns
include changes in integrin subunit expression with clinical stage,
and over- or underexpression of certain integrins have been
observed in malignant colon tissues compared to normal epithe-
lium (Stallmach et al, 1992; Streit et al, 1996).
Once tumour cell adhesion has occurred it must be stabilized,
and integrins and integrin-mediated signal transduction are appar-
ently important in this process. Transmembrane integrin receptors
can be linked through the cell membrane to cytoskeleton compo-
nents (Chen et al, 1994), such as microfilaments, and they are
thought to be important factors in adhesion stabilization, but their
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Summary Integrin-mediated tumour cell adhesion to extracellular matrix (ECM) components is an important step in the development of
metastatic lesions. Thus, integrin expression and integrin-mediated adhesion of colon carcinoma cells to various ECM components was
examined. Poorly (HT-29P) and highly (HT-29LMM) liver-metastatic colon carcinoma cells were used to study the rates of adhesion to
collagen I (C I), collagen IV (C IV), laminin (LN), fibronectin (FN), or vitronectin (VN) in a static adhesion assay (10–120 min). Cells were
untreated or treated with oligopeptides (RGD, GRGDS, YIGSR, RGES), anti-integrin antibodies, or colchicine, nocodazole, cycloheximide,
acrylamide or cytochalasin D (to disrupt cytoskeletal structures). Both cell lines expressed similar patterns of integrin expression (a2, a3, a6,
av, b1, b4 and b5) by immunocytochemistry and immunoprecipitation. HT-29LMM cells showed significantly higher rates of adhesion to LN
(P < 0.001) and FN (P < 0.001), but significantly poorer rates of adhesion to C I (P < 0.05) and C IV (P < 0.001) than HT-29P cells,
respectively, adhesion to VN was insignificant. RGD and GRGDS inhibited HT-29LMM cell adhesion to FN only. Pretreatment with anti-b1 or
anti-a2 integrin subunits suppressed adhesion to C I and C IV, and adhesion to LN was inhibited with anti-b1 or anti-a6 integrin. Anti-b1 or anti-
av blocked adhesion to FN. Pretreatment of cells with cytochalasin D, cycloheximide or acrylamide inhibited adhesive interactions of both cell
lines to the ECM components. In contrast, colchicine and nocodazole had no effect. The results demonstrate that adhesion of HT-29 cells to
ECM is mediated, in part, by different integrins, depending on the substrate. Poorly and highly metastatic HT-29 cells possessed different
patterns of adhesion to the various ECM substrates, but these differences were not due to different expression of integrin subunits. The
results also suggested that the initial adhesion of poorly or highly metastatic HT-29 cells to ECM components requires, in part, the presence
of native action and intermediate filaments, but not of microtubules. Thus the adhesion of tumour cells to ECM components may be
dependent on signal transduction and assembly of microfilaments.
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Cytoskeletal proteins can be linked to transmembrane receptors in
adhesion plaques to form supramolecular complexes (reviewed by
Schwarz et al, 1995). Important integrins in this process are the
b1-integrins, which are linked to actin, a-actinin and talin, which
are further connected to various other cytoskeleton proteins like
vinculin and zyxin (Horwitz et al, 1986; Yamada and Geiger,
1997). Integrin signals that mediate interactions with cytoskeleton
components can be induced by the binding and clustering of inte-
grins at the cell surface (Jewell et al, 1995; Miyamoto et al, 1995).
This process may also be linked to phosphorylation events,
because during adhesion phosphorylation, mainly on tyrosine
residues, occurs and this, in turn, may activate several intracellular
signaling cascades (Kornberg et al, 1991; Akiyama et al, 1994).
Different complexes may be involved, such as focal adhesion
kinase-paxillin (Guan et al, 1991; Akiyama et al, 1994; Jewell
et al, 1995) or Grb2-SOS (Mainiero et al, 1995) complexes.
Recent studies have shown that cytoskeleton components are also
linked to signal transduction processes (Ben-Ze’ev, 1997). These
complex interactions form signalling cascades that are organized
in hierarchic systems and connect integrin-mediated signalling
with other intracellular signalling and adhesion systems (Mainiero
et al, 1995).
Much of the data on integrin-mediated signal transduction were
obtained using fibroblasts or non-epithelial tumour cells, and the
differences in phosphorylation patterns and involvement of
cytoskeleton components could be related to cell origin. Since cell
signalling cascades are likely to be different in different cell
systems, we used poorly and highly liver-metastatic human colon
carcinoma cell lines of epithelial cell origin to examine the adhe-
sion properties to various ECM components. We also examined
the involvement of intermediate filaments, actin and microtubules
in adhesive interactions of these cells with ECM components.
MATERIALS AND METHODS
Materials
Dulbecco’s modified Eagle’s medium/F12 medium (DMEM/F12,
1:1 v/v) were purchased from Irvine Scientific; fetal bovine serum
(FBS) from GibcoBRL; FN, laminin (LN), collagen I (C I) and IV
(C IV) were obtained from Collaborative Biomedical Products.
Vitronectin (VN) was purified as described (Yatohgo et al, 1988),
and its purity tested using Western blotting. Mouse anti-a3- and
a5-integrins monoclonal antibodies (mAb) were from Cal-
biochem; anti-av- and b3-integrin from Zymed; anti-b1-, a1-, a2-
and  a6-integrin, rat- and mouse-IgG, goat-anti-mouse- and
goat-anti-rat-IgG-HRP were from Harlan Serotec. Anti-b4-integrin
was obtained from Chemicon, anti-b5-integrin was from Upstate
Biotech. All anti-integrin antibodies (except anti-b5) had blocking
properties for adhesion. RGD-, GRGDS-, RGES- and YIGSR-
peptides were obtained from Sigma. Cytochalasin D and nocoda-
zole were products of Calbiochem; acrylamide was obtained
from Biorad; colchicine and cycloheximide from Sigma; and
CalceinAM from Molecular Probes.
Cell lines
We used poorly (HT-29P) and highly (HT-29LMM) liver-
metastatic colon carcinoma cells to study adhesion properties. The
HT-29LMM subclone was obtained from intraspleenic injection in
nude mice (Price et al, 1989). Cells were cultured in DMEM/F12
medium containing 10% FBS without antibiotics in humidified
5% carbondioxide 95% air at 37°C. Only cells of fewer than
15 passages were used. Cells were harvested with Trypsin–EDTA
during the log-phase of growth. After trypsinization, cells were
resuspended in adhesion medium (DMEM/F12 1:1, bovine serum
albumin (BSA) 1%) at room temperature for 30 min for recon-
stitution of surface proteins and washed extensively in
calcium–magnesium-free phosphate-buffered solution (CMF-
PBS).
Adhesion assay
Microtiter plates (96-well, Corning) were coated with C I (50 mg
ml–1), C VI (50 mg ml–1), LN (50 mg ml–1), FN (50 mg ml–1), VN
(10 mg ml–1) or 1% BSA (negative control) at 37°C for 3 h (150 ml
per well). Effective concentrations were determined in previous
experiments (data not shown). Blocking of non-specific binding
sites was performed using 1% BSA (37°C, 30 min, 200 ml per
well). During reconstitution of surface proteins in adhesion
medium, cells were fluorescence-labelled with CalceinAM (15 mg
per 15 ml). After washing, cells were resuspended in adhesion
medium at a final concentration of 0.5 ´ 106 cells per ml. Control
experiments were performed to demonstrate that the CalceinAM
did not affect cell viability or adhesion properties.
Adhesion experiments were performed with 150 ml cell suspen-
sion per well for different times (10–120 min) as previously
described (Haier et al, 1998). For investigation of integrin-
mediated cell adhesion, cells were pretreated with monoclonal
antibodies (mAb) to integrin subunits (with IgG as a negative
control). Inhibition was calculated by comparing adhesion of
untreated (set to 100% adhesion) and treated cells. All data are
given as relative percentage of adhesion compared to untreated
cells. In other experiments cells were incubated with colchicine
(10–100 mgM, 15 min) or nocodazole (0.5–5 mg ml–1, 60 min) to
disrupt microtubules, or with cycloheximide (10–100 mM, 60 min)
or acrylamide (10–100 mM, 60 min) to disrupt intermediate fila-
ments or with cytochalasin D (5–50 mM, 15 min) to disrupt actin
filaments prior to the adhesion assay. Pretreatment was done at
37°C. Experiments were performed in triplicate and repeated
twice. In the case of cytochalasin D and nocodazole control cells
were treated with the same amount of dimethyl sulphoxide
(DMSO) (5 ml ml–1) to exclude non-specific effects of the reconsti-
tution solution. Control experiments were performed to document
the effects of the drugs on disrupting cytoskeletal components in
HT-29 cells.
Integrin expression
Integrin expression was examined using cells bound to coated
glass slides. Chamber slides (4-well, Nunc) were pretreated with
ECM components or anti-integrin mAb (1 mg per 0.5 ml) using the
same conditions as for microtiter-plates. Coating with non-specific
mouse IgG was used as a negative control. Reconstituted untreated
cell suspensions (0.5 ml per chamber) were added to ECM
pretreated slides. Adhesion was performed as described above
in FBS-free adhesion medium. After 120 min, non-adherent cells
were removed by washing with CMF-PBS. Adherent cells were
visualized with haematoxylin stain. Semiquantitative analysis
was done using a Zeiss microscope. Additionally, integrins were
immunostained at the cell surface. After incubation of cell
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removed and the remaining cells were fixed using Conroy’s solu-
tion (30% methanol, 70% acetic acid). After washing and blocking
of non-specific binding (20% horse serum in PBS), cells were
incubated with anti-integrin mAb (1 mg per 0.3 ml). Non-specific
IgG was used as a negative control to evaluate background
binding. For all experiments, non-specific staining was not seen.
Following intensive washing, anti-species-specific mAb labelled
with horseradish-peroxidase (1 mg per 0.3 ml) was added. Specific
binding was visualized with AEC substrate (Coulter Immunotech)
according to the manufacturer’s guidelines. Counterstaining was
performed with haematoxylin and semiquantitative analysis was
performed by microscopy using a Zeiss microscope.
Immunoprecipitation of biotinylated integrins
Cells were grown to 70–80% confluence in a 100-mm culture dish,
culture medium was removed and cells were washed extensively
with cold Buffer A (20 mM sodium hydrogen carbonate, 0.15 M
sodium chloride (NaCl), pH 8.0). For biotinylation of surface
molecules 1 mg NHS-LC-Biotin (Pierce) was added in 4 ml Buffer
A (4°C for 90 min). After extensive washing with Buffer A, cells
(~107 cells per dish) were lysed in 4 ml modified RIPA buffer
(PBS containing 1.0% NP40, 0.25% deoxycholate, 0.1 mM
phenylmethylsulphonyl fluoride, 0.1 mM TLCK, 0.1 mM iodoac-
etamide, 10 mg ml–1 leupeptin and 10 mg ml–1 aprotinin; pH 7.4) at
4°C for 30 min. Cell lysates were centrifuged at 13 000 g for 10
min to remove insoluble material. After preclearing each cell
lysate (30 min, 37°C) with 20 ml anti-mouse-IgG-Agarose per ml,
supernatants were incubated with 1–5 mg anti-integrin-mAb for 2
h (at 37°C or at 4°C overnight). Precipitates were obtained by
addition of 20 ml anti-mouse (rat)-IgG-Agarose (2 h at 37°C or at
4°C overnight). The agarose beads were washed 5 ´ with 3 ml
RIPA buffer, sodium dodecyl sulphate (SDS) sample buffer (100
ml) was added to beads and the mixtures were incubated at 95°C
for 5 min. SDS polyacrylamide gel electrophoresis (SDS-PAGE)
(10%) was performed under non-reduced or reduced conditions.
After blotting to polyvinylidene difluoride (PVDF) membranes
(100 V, 1 h), the membranes were blocked in blocking buffer
(10 mM TRIS,50 mM NaCl, 1% Tween-20, pH 7.5) containing 3%
BSA and incubated in blocking buffer (0.5% BSA) with strepta-
vidin-AP (Boehringer-Mannheim) for detection of biotinylated
integrins. After washing, the colour reaction was developed with
BCIP/NBT solution (Zymed) and stopped with dH2O.
RESULTS
Surface expression of integrins
The expression of different integrin subunits was evaluated using
immunocytochemical staining of immobilized HT-29 cells.
Intense staining was obtained for a2, a3, a6, b1 and b4 subunits. A
weaker signal was seen using av- and b5-mAb. Integrin subunits
a1, a5 and b3 were not detected. Cells bound to immobilized mAb
on glass slides in a relationship similar to that found by immuno-
cytochemical localization of integrin receptors on immobilized
cells. Lower amounts of cells bound to immobilized anti-av mAb
than to the other anti-integrin-mAbs. Differences were not found
between poorly (HT-29P) and highly (HT-29LMM) metastatic cell
lines (Table 1).
Immunoprecipitation of integrins
To confirm the immunocytochemical data and exclude that these
results reflect changes in the accessibility of integrins but not in
integrin surface expression, integrin subunits were evaluated using
immunoprecipitation of biotinylated surface proteins. Intense
bands were obtained for a2, a3, a6, b1 and b4 subunits. Weaker
bands were seen using av- and b5-mAbs. Integrin subunits a1, a5
and b3 were not detected. Differences were not found between
poorly (HT-29P) and highly (HT-29LMM) metastatic cell lines
(Figure 1). These results supported the findings that both cell lines
expressed similar patterns of integrins on their surfaces.
Adhesion of colon carcinoma cells to ECM 1869
British Journal of Cancer (1999) 80(12), 1867–1874 © 1999 Cancer Research Campaign
Table 1 Immunocytochemical staining of integrin subunits on HT-29 cells
and binding of cells to immobilized anti-integrin mAbs
Integrin Expression Integrin Cell binding
HT-29P HT-29LMM HT-29P HT-29LMM
Mouse IgG – – Mouse IgG – –
Alpha 1 – – Alpha 1 – –
Alpha 2 +++ +++ Alpha 2 +++ +++
Alpha 3 +++ +++ Alpha 3 +++ +++
Alpha 5 – – Alpha 5 – –
Alpha 6 ++ ++ Alpha 6 +++ +++
Alpha v + + Alpha v + +
Beta 1 +++ +++ Beta 1 +++ +++
Beta 3 – – Beta 3 – –
Beta 4 +++ +++ Beta 4 +++ +++
Beta 5 + + Beta 5 + +
Cells were stained on glass slides or binding was measured to immobilized
anti-integrin mAbs on glass slides according to Methods. Staining or binding:
+++ intense; ++ moderate; + weak or single cell; – none.
HT-29P
HT-29LMM
HT-29P
HT-29LMM
b1 b3 b4 b5
b1 b3 b4 b5
a1 a2 a3 a6 av a5
av a1 a2 a3 a6 a5
Figure 1 Integrin expression on HT-29 cells. Immunoprecipitation of
biotinylated surface proteins was performed using mAb against various
integrin subunits. Precipitates were separated by SDS-PAGE under reduced
conditions. Detection of (A) b-integrins and (B) a-integrins in HT-29P cells;
(C) b-integrins and (D) a-integrins in HT-29LMM cells was done by
streptavidin–alkaline phosphataseAdhesion to ECM components
Time-dependent cell adhesion to ECM components was measured
until a plateau rate was obtained. Plateau values were obtained
after 60 min using C I and C IV, whereas cells reached maximal
adhesion to LN and FN after 90–120 min. In both cell lines high
adhesion rates were observed to C I, C IV and LN; however, a poor
rate of adhesion was demonstrated for FN using HT-29LMM cells,
and FN-adhesion was not found using HT-29P cells. Adhesion to
VN was not significant. HT-29LMM cells had significantly poorer
rates of adhesion to C I (P < 0.05) and C IV (P < 0.001), but
significantly higher rates of adhesion to LN (P < 0.001) and FN
(P < 0.001) than HT-29P cells (Table 2).
Inhibition of cell adhesion with anti-integrin antibodies
For tumour cell adhesion inhibition studies, values were compared
after 120 min (plateau values). Results are given as relative
amounts of attached treated cells compared to untreated cells (set
to 100%). Pretreatment with anti-b1 integrin subunit suppressed
adhesion of both cell lines (HT-29P/HT-29LMM) to C I
(7%/18%), C IV (13%/24%) and LN (0%/0%). Adhesion to C I
and C IV was inhibited with anti-a2 (C I: 31%/40%; C IV:
66%/57%). Inhibition of adhesion to LN was achieved using anti-
a6 (24%/16%). Anti-av blocked adhesion (55%) of HT-29LMM
cells to FN. Negative controls with non-specific IgG showed no
effect on cell adhesion. Cell adhesion was inhibited in a concentra-
tion-dependent manner (data not shown). Differences in adhesion
were not seen using antibodies against a1,  a3,  a5,  b3 or
b4-subunits. The anti-b5-integrin antibody had no blocking
capabilities. Therefore, the potential role of b5-integrins in
integrin-mediated adhesion was not investigated.
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Table 2 Relative adhesion of poorly and highly metastatic HT-29 cells to
various ECM components
ECM
HT-29P (Per cent adhesion) HT-29LMM (Per cent adhesion)
component 10 min 30 min 120 min 10 min 30 min 120 min
C I 13 ± 5 51 ± 7 63 ± 32   ± 0 41 ± 3 58 ± 3a
C IV 3 ± 1 27 ± 6 41 ± 90   ± 0 14 ± 3 19 ± 3b
VN 0 ± 00   ± 01   ± 00   ± 00   ± 02   ± 0
LN 0 ± 07   ± 1 36 ± 22   ± 0 17 ± 1 45 ± 4b
FN 0 ± 00   ± 01   ± 00   ± 02   ± 0 20 ± 8b
Adhesion is expressed as % cell adhesion or relative fluorescence at
different times compared to total fluorescence in the cell suspension;
background fluorescence was calculated using adhesion to BSA-coated
surface and was subtracted; background fluorescence was below 1% in all
experiments. aP < 0.05; bP < 0.001 compared to HT-29P cells after 120 min.
Table 3 Inhibition of HT-29 tumour cell adhesion to ECM components with cytoskeletal disrupting agents
Percent adhesion
ECM component Cytochalasin D Colchicine Nocodazole Acrylamide Cycloheximide
(10 mM) (50 mM) (2.5 mg ml–1) (50 mM) (50 mM)
HT-29P
C I 1a 96 99 27b 49
C IV 3a 96 106 25b 45b
LN 6a 107 175 56b 30b
HT-29LMM
C I 1a 94 124 41b 56b
C IV 12a 90 81 44b 33b
LN 11a 118 88 65b 54b
Inhibitory effects are expressed as relative (%) adhesion compared to untreated cells (100%); effect of cytochalasin D and nocodazole
were evaluated by comparison with DMSO-treated cells (5 ml ml–1). aP < 0.005; bP < 0.001 compared to untreated cells.
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Figure 2 Inhibition of adhesion of HT-29 cells to ECM components with
cycloheximide. Cells were pretreated with 50 mM cycloheximide for 60 min at
37°C; relative amounts of adhered treated cells were compared to untreated
cells (= 100% adhesion) after 120 min
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Figure 3 Concentration-dependent inhibition of adhesion of HT-29LMM
cells to ECM components. Cells were pretreated with 5–50 mM acrylamide for
60 min at 37°C, and relative amounts of adhered treated cells and untreated
cells (= 100% adhesion) were compared after 120 minInvolvement of cell cytoskeleton in tumour cell
adhesion
Treatment with colchicine did not affect tumour cell adhesion to
ECM components (Table 3). Inhibitory effects are shown as per
cent of attached treated cells compared with untreated cells (set to
100%). However, there was a concentration-dependent inhibition
of adhesion using cycloheximide (30–56% adhesion) or acryl-
amide (44–66% adhesion) (Figures 2 and 3). Longer incubation
times produced no further inhibitory effects, but the total adhesion
was reduced. Additionally, we found strong inhibition (1–12%
adhesion) using cytochalasin D, a drug that disrupts actin-fila-
ments. Treatment with DMSO alone had only a minimal inhibitory
effect. In previous studies it was shown that the concentrations of
drugs that were used resulted in disruption of microfilaments and
cytoskeleton components (Chopra et al, 1991; Seufferlein and
Rozengurt, 1994; Tang et al, 1994), and this was confirmed in the
present studies (data not shown). Significant inhibition of adhesion
was demonstrated independent of the type of ECM component
used as a substrate with either cell line after 30–120 min.
DISCUSSION
Specific integrin-mediated interactions between tumour cells and
ECM in particular host organs are thought to be important for
organ-specific metastasis formation. In colon carcinomas integrin
expression differs depending on the metastatic potential of the
tumour cell. Additionally, the quantitative expression of ECM
components is organ-dependent (Nicolson, 1988b), and relation-
ships between ECM interaction and differentiation state or behav-
iour of colon carcinoma cells have been described (Grigioni et al,
1986; Boyd et al, 1988; Danecker et al, 1989). In our study, the
properties of poorly or highly metastatic colon carcinoma cell lines
were analysed during adhesion to different ECM components.
Both colorectal cell lines expressed similar patterns of integrins.
Differences were not seen in conventional immunostaining or in
the binding of cells to immobilized antibodies against various inte-
grins. Intense staining was found for a2-, a3-, a6- and b1-integrin
subunits in both cell lines. A weaker signal was seen using av-
mAb in both cell lines. Integrin subunits a1, a5 and b3 were not
detected. Cells bound to immobilized mAbs on glass slides similar
to immunocytochemical localization of receptors on immobilized
cells. Lower amounts of cells adhered to anti-av mAb than to the
other positive integrins (a2,  a3,  a6,  b1). These results were
confirmed using immunoprecipitation of biotinylated integrins.
Taken together it was shown that the surface expression of the
tested integrin subunits was comparable in both cell lines.
Furthermore, the results suggested that adhesion of HT-29 cells is
mediated, in part, by different integrins, depending on the ECM
components used in the adhesion experiments.
Poorly and highly metastatic HT-29 colorectal carcinoma cells
possessed different patterns of adhesion to the various ECM
substrates. The main difference found was in the adhesion to FN,
which was only seen with HT-29LMM cells. Using other
subclones of HT-29 cells, Danecker et al (1989) found similar
differences in the adhesion behaviour of colorectal carcinoma
cells, with poorly differentiated cell clones adhering better to FN.
In contrast to other studies (Schreiner et al, 1991; Lehmann et al,
1994; Herzberg et al, 1996), we detected little or no adhesion of
HT-29P cells to FN or VN under the conditions used for the adhe-
sion assays. In previous studies with the HT-29LMM subclone, a
higher rate of adhesion to liver endothelial cells was demonstrated
compared to endothelial cells derived from lung (Sawada et al,
1996). According to our inhibition data, binding to C I, C IV, LN
and FN were mediated by different types of b1-integrins. The inte-
grin a2b1 was identified as likely to be responsible for the adhesive
interactions with the collagens, and the a6 b1-integrin was likely to
be involved in the binding to LN. As previously described (Haier
et al, 1998), RGD-inhibition of adhesion to FN was probably due
to interference with FN-avb1 integrin interactions.
In our study different adhesion properties of HT-29P and 
HT-29LMM cells were not caused by differences in integrin
expression, because we could not demonstrate a correlation
between integrin expression and adhesion to ECM components.
Previously it has been shown that the integrin expression of HT-29
cells was also independent from the state of differentiation of these
cells (Schreiner et al, 1991). The moderate adhesion to LN was not
mediated by the a6b4-integrin. These results are in contrast to other
studies, where this integrin was responsible for adhesion to LN
(Orian-Rousseau et al, 1998). This difference may explain that the
adhesion to LN was only moderate whereas other groups found
higher rates of adhesion to this ECM component (Herzberg et al,
1996; Orian-Rousseau et al, 1998). We cannot completely rule out
that different b5- or b6-integrin expression is related to different
adhesive properties to FN. Recently, the avb6 was found as a
possible FN receptor on HT-29 cells, despite the very low levels of
avb6 and the much higher levels of avb5 (Kemperman et al, 1997).
Both b-subunits, which were associated with the av -subunit, were
shown to be involved in adhesion of HT-29 cells to FN and VN
(Lehmann et al, 1994). Various studies demonstrated that the
a5-integrin might be involved in the tumorigenicity and metastatic
behaviour of colorectal carcinoma cells. Using immunohistochem-
istry it was shown that less differentiated and metastatic lesions
possessed higher expression of the a5-subunit than normal mucosa
or primary well-differentiated tumours (Streit et al, 1996).
Differences were also found at the mRNA level, where highly
metastatic colon carcinoma cell lines had higher amounts of
a5-mRNA than poorly invasive sublines. Transfection of poorly
metastatic cells leads to an increase in tumorigenicity in athymic
mice (Gong et al, 1997). However, these integrins are not involved
in adhesion to collagens or LN, and differences in the expression
would not explain different adhesive properties to these ECM
components.
Our findings suggest that different intracellular events during
cell adhesion may explain the differences in adhesion between
poorly and highly metastatic colorectal tumour cells, or non-inte-
grins mediated the differences in cell adhesion. Thus, overexpres-
sion of a single or few adhesion molecules alone cannot explain
the different metastatic adhesive phenotypes. It is more likely that
alterations in the affinity of integrins and their membrane distribu-
tions might be more important in the progression of colon carci-
noma cells (Kim et al, 1994). Alternatively, differences in their
metastatic behaviour may be explained by other tumour cell prop-
erties. The functional status of integrins, which are known for their
activation or changes in affinity after binding to ECM components,
is regulated by complex interactions with a number of cytosolic,
cytoskeletal and membrane-bound proteins. Cells can modulate
integrin-binding affinities and kinetics of interactions between
integrin receptors and their adhesive ligands. These adhesion
complexes serve both as recipients and as generators of signalling
information that includes structural and signalling functions. For
example, cell adhesion receptors can generate regulatory signals
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invasion into the host organ.
Local regulation of cytoplasmic processes, including alteration
of the cytoskeleton, secretion and the control of adhesion itself, are
prominent features of integrin-mediated signalling (Gumbiner,
1996). As cells adhere to ECM components, integrins become
localized in areas of focal contacts (Kornberg et al, 1991; Seftor
et al, 1992). Focal contacts may function in signal transduction
events, and they might be essential for some functions of b1-inte-
grins. Redistributions of integrins in forming focal contacts during
adhesion can lead to activation of the intracellular integrin domain,
modulating interactions with the cytoskeleton. Components of the
tumour cell cytoskeleton (microtubules, microfilaments and inter-
mediate filaments) have been reported in such complexes, and
their organization can affect metastatic ability, since disruption of
these components can result in decreases in metastatic properties.
For example, B16 melanoma cells formed fewer lung colonies
than control cells after treatment with cytochalasin D and cyclo-
heximide. However, colchicine failed to inhibit lung colony
formation (Ben-Ze’ev and Raz, 1985; Chopra et al, 1990). Neither
colchicine nor cycloheximide treatment altered initial pulmonary
arrest or adhesion to murine microvessel-derived endothelial cells
(Chopra et al, 1988). The ability of tumour cells to aggregate
homologous platelets is inhibited by the disruption of microfila-
ments and intermediate filaments but not on disruption of micro-
tubules (Chopra et al, 1990). Mooney and colleagues (Mooney
et al, 1995) found a rapid increase of F-actin in hepatocytes after
spreading on different ECM components, but microtubules assem-
bled slowly. In contrast, cell spreading could be completely
inhibited by combining suboptimal doses of cytochalasin D and
nocodazole, suggesting that intact microtubules can stabilize cells
when the microfilament network is partially compromised.
In our study, we demonstrated that adhesion of colon carcinoma
cells to ECM components can be inhibited by treatment with
cycloheximide/acrylamide and cytochalasin D. However, no effect
was found after disruption of microtubules with colchicine. Short
incubation times with cycloheximide and similar results using
acrylamide ruled out that the demonstrated effects were dependent
on protein synthesis. Longer incubation times (up to 3 h) had no
additional effects on inhibition, but the total amounts of adhesion
were reduced. We conclude that the initial adhesion of poorly and
highly metastatic HT-29 cells to ECM components requires, in
part, presence of native intermediate filaments and actin filaments,
but not microtubules. The results also suggest that adhesion of
tumour cells to ECM components may be dependent on signal
transduction, and native microfilaments appear to be necessary for
this process.
The cytoskeleton not only controls cell morphology but also
regulates cell growth, migration, differentiation and gene expres-
sion, events which are fundamental to embryogenesis, carcinogen-
esis and wound healing (Varedi et al, 1997). During cell adhesion
different cytoskeleton components are colocalized with integrins
in adhesion plaques (Meijne et al, 1994), and microfilaments are
part of the plaque actin–myosin complex. In non-muscular cells
actin has both a major contractile function and a cytoskeletal role.
In these cells actin is attached mainly to the cytoplasmic surface of
the cell membrane, either directly or through other proteins linked
to certain intrinsic transmembrane proteins. Intermediate filaments
enmesh the nucleus, and play a role in maintenance of nuclear-
cytoplasmic pathways. Cytoskeletal proteins are involved in
protein kinase C and Ca2+/calmodulin-dependent protein kinase II
signalling pathways that involve phosphorylation of intermediate
filaments (Ogawara et al, 1995; Inagaki et al, 1997). Additionally,
it was shown that cGMP- and cAMP-dependent protein kinases
(Lamb et al, 1989; Wyatt et al, 1991) can also be involved in phos-
phorylation of intermediate filaments following their rearrange-
ment. Microtubules are part of the cytoskeleton and take part in
intracellular transport. The major component of microtubules is
tubulin (Kreis and Vale, 1993), and this molecule also seems to be
integrated in intracellular signalling and is related to intermediate
filaments (Gurland and Gundersen, 1995).
Disruption of cytoskeletal proteins can change various cell
functions, such as mRNA and protein expression of proteinases
(Botteri et al, 1990; Young et al, 1994). Furthermore, it has been
described that cycloheximide and acrylamide specifically disrupt
the organization of the intermediate filament system in CV-1
kidney cells with no discernable effects on microtubules or micro-
filaments (Sharpe et al, 1980). The presence of intermediate
filaments coincided with loss of anchorage dependency in several
head and neck squamous cell carcinoma cell lines (Tomson et al,
1996). Integrins function as integrative elements in cytoskeletal
arrangements and are involved in signalling events (Yamada and
Miyamoto, 1995). Disruption of several cytoskeletal proteins,
including actin and intermediate filaments, interferes with inte-
grin-mediated phosphorylation of intracellular proteins (Tang et al,
1993). Furthermore, cytoskeletal arrangements and integrin
surface expression seem to be related. Hendrix et al (1996, 1997)
described morphological and biological changes, such as tumori-
genicity, invasiveness and integrin expression of different carci-
noma cell lines, that were associated with direct linkages between
intermediate filaments. The remodelling of matrigel, a model
ECM matrix, by tumour cells was associated with a6b4 integrin
expression in several cell lines and can be blocked by cytochalasin
(Rabinovitz and Mercurio, 1996). Phosphorylation of intermediate
filaments and other cytofilaments appears to be involved in
cytoskeletal rearrangements, and integrins may trigger these
events.
In summary, our data support the notion that microfilaments and
intermediate filaments play a profound role in colorectal carci-
noma cell adhesion stabilization and signal transduction into the
cell during cell adhesion. As shown for B16 melanoma cells
(Chopra et al, 1991), actin and intermediate filaments appear to be
also involved in adhesion of tumour cells to ECM components,
whereas tubulin disruption had no effect on cell adhesion.
Regulation of adhesion-mediated signals occurs at various levels,
and cytoskeleton interactions and rearrangement of cytoskeletal
components appear to play roles in these complex processes.
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